Stocks
Prenetics Global LimitedPRE
NASDAQHealthcareDiagnostics & Research$20.72-0.29%
Specializing in genetic and diagnostic testing, this company provides at-home health testing kits and COVID-19 screening solutions. Investors monitor Prenetics for its growth in the personalized medicine space and pandemic-related testing contracts.
Market Cap: $291.2M52W Range: $3.10 – $22.86
Congressional Interest in Prenetics Global Limited (PRE)
3 members of Congress have disclosed 12 trades in Prenetics Global Limited (PRE), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
3
Buys
8
Sells
4
Who in Congress Is Trading PRE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-09-03 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-06-19 | Susan M Collins | sell | $1K – $15K |